genia tagger: 191('biotin', 6)
('pdefpcr', 2)
('antisense', 2)
('sites', 4)
('human', 6)
('cagctgctcgatggc', 2)
('primer', 12)
('revealed', 6)
('anti-dna-hrp', 2)
('25', 22)
('26', 10)
('luciferase', 30)
('family', 4)
('\\>', 16)
('\\?', 54)
('\\=', 122)
('28', 20)
('0', 829)
('\\%', 122)
('actin', 12)
('4', 171)
('factor', 10)
('biotinylated', 2)
('suppressor', 4)
('endogenous', 10)
('\\(', 489)
('\\)', 489)
('mda-mb-231', 2)
('assay', 40)
('activity\\.', 9)
('rna', 70)
('p11', 58)
('breast', 4)
('untreated', 5)
('secondary', 4)
('pdef-negative', 20)
('pbs', 14)
('pc3', 4)
('proteins', 6)
('50', 58)
('tumors\\.', 6)
('survivin', 135)
('vector', 30)
('mrna', 18)
('299', 2)
('mo', 332)
('pcdna3\\.1', 32)
('-gggctgagtcctcaattttgaag-3', 2)
('sequence', 8)
('195', 2)
('fl-142', 2)
('hose', 31)
('ihc', 20)
('prostate-derived', 2)
('80', 28)
('penicillin', 2)
('shaking\\.', 2)
('factors', 6)
('pdef\\+', 4)
('ovarian', 198)
('cell', 264)
('tma', 18)
('survivin\\.', 4)
('irb', 2)
('moderate', 8)
('glyceraldehyde-3-phosphate', 2)
('ov432', 4)
('1\\+', 6)
('reporter', 4)
('cdna', 34)
('weak', 6)
('vd3', 52)
('167-bp', 2)
('bp', 8)
('region', 4)
('100', 38)
('strong', 10)
('104', 8)
('stage', 102)
('ets', 16)
('1640', 6)
('fig\\.', 56)
('\\/\\+', 24)
('msa\\.', 6)
('dna-lipofectamine', 4)
('tumor', 168)
('pcr', 54)
('products', 10)
('tma\\.', 4)
('antibody', 22)
('\\/sub', 6)
('acggc-3', 2)
('ttcatccactg-3', 2)
('protease', 2)
('cancer', 114)
('-gtgaggagagctggaccgac-3', 2)
('h4', 2)
('58', 6)
('60', 10)
('2\\.8\\-kb', 4)
('anti', 72)
('65', 2)
('marker', 7)
('table', 22)
('total', 32)
('\xc3\x97', 16)
('rpci', 6)
('dehydrogenase', 2)
('skov3', 4)
('tumour', 28)
('skov6', 4)
('positive', 50)
('pdef\\.', 4)
('negative', 51)
('construct', 22)
('anti-histone', 2)
('avidin\xe2\x80\x93biotin', 2)
('2', 370)
('promoting', 2)
('msa', 44)
('survivin-positive', 3)
('pdef', 368)
('constructs', 4)
('tbs-t', 8)
('favorable', 6)
('rabbit', 6)
('iib', 15)
('line', 85)
('iii', 32)
('10', 156)
('b', 708)
('dna', 54)
('19', 18)
('cells', 86)
('3\\+', 6)
('rnas', 6)
('promoter', 37)
('n', 4974)
('rpmi', 8)
('pbs\\.', 2)
('monoclonal', 2)
('2\\+', 6)
('distribution', 8)
('\xc2\xb5g', 34)
('and', 484)
('motif', 4)
('ebs', 6)
('binding', 2)
('ii', 53)
('epithelial', 8)
('sense', 4)
('protein', 36)
('-tcagatggggtgcacgaactggt-3', 2)
('transcription', 18)
('prl-tk', 4)
('isolated', 4)
('40', 41)
('1', 483)
('complex', 6)
('5', 219)
('figures', 2)
('peroxidase', 2)
('goat', 8)
('mock', 14)
('-gcttcccgttctcagccttgac-3', 2)
('dna-histon', 2)
('prognostic', 5)
('normal', 83)
('8\\/13', 4)
('75', 2)
('pluc-survivin', 2)
('core', 16)
('data', 34)
('antibodies', 6)
('primers', 10)
('ebss', 4)
('i', 5454)
('expression', 210)
('lines', 50)
('gapdh', 8)
('methods\\.', 2)
('antiapoptotic', 2)
('hrpo-conjugated', 2)
('-gaggctggc', 2)
('invasion\\.', 2)
('cores', 4)
('2008', 16)
('h2b', 2)
('h2a', 2)
('\\\xe2\\\x80\\\x9cggaa\\/t', 2)
('pdef-specific', 4)


spacy + metamap: 656('cincinnati', 2)
('positive control', 2)
('duplicates', 2)
('four', 6)
('microtiter plate', 2)
('tumours', 4)
('expressions', 2)
('primer', 12)
('duplicated', 2)
('inverse', 21)
('actin antibody', 2)
('tx', 2)
('recurrence', 6)
('foster', 2)
('tk', 6)
('tissue procurement', 4)
('cdna', 34)
('assay', 40)
('survival rate', 8)
('apoptosis', 54)
('activation', 8)
('radiation resistance', 2)
('figs', 8)
('rnase', 2)
('categories', 4)
('tri', 46)
('\\%\\ positive', 6)
('pbs', 14)
('level', 29)
('evaluation', 3)
('prolonged', 5)
('vector', 30)
('inspection', 2)
('cell lines', 30)
('tek', 2)
('ten', 30)
('triplicate', 2)
('ovarian cancer', 86)
('antigen', 2)
('consistent', 6)
('estimates', 8)
('biology', 2)
('understanding', 2)
('past', 2)
('fold', 4)
('rate', 42)
('value', 12)
('patient', 79)
('elisa', 12)
('blue', 6)
('tumorigenicity', 2)
('abc', 4)
('sub', 24)
('abi', 18)
('section', 6)
('disease', 26)
('recommendation', 2)
('ovarian', 198)
('cell', 264)
('template', 4)
('international', 2)
('peroxidase activity', 2)
('method', 13)
('contrast', 2)
('proliferation', 30)
('tumor cell lines', 2)
('reporter', 4)
('normal tissue', 12)
('water', 2)
('tnm', 8)
('amplification', 4)
('groups', 8)
('strong', 10)
('change', 20)
('skim milk', 4)
('study', 5)
('vectors', 4)
('reports', 2)
('products', 10)
('usually', 4)
('reagents', 6)
('gene', 6)
('studies', 8)
('options', 2)
('invasiveness', 4)
('diameter', 2)
('family', 4)
('highly', 6)
('tumor sample', 10)
('total', 32)
('estimate', 18)
('warning signs', 2)
('dna', 54)
('cell proliferation', 16)
('positive', 50)
('control vector', 2)
('negative', 51)
('few', 2)
('duplicate', 10)
('criteria', 4)
('black', 2)
('means', 2)
('manufacturer', 12)
('more', 9)
('0\\%', 52)
('company', 2)
('firefly luciferase activity', 2)
('transient', 4)
('biotin', 6)
('rabbit', 6)
('excellent', 2)
('cases', 8)
('iii', 32)
('women', 2)
('high', 46)
('mg', 2)
('ma', 247)
('mb', 34)
('ml', 12)
('mo', 332)
('endogenous', 10)
('incubator', 2)
('values', 6)
('following', 10)
('inhibitor', 6)
('10\\%', 14)
('il', 98)
('control', 37)
('motility', 2)
('ovarian tumour', 8)
('agarose gel', 4)
('sample', 35)
('death', 14)
('numbers', 4)
('western blot', 32)
('serum', 8)
('presumptive', 2)
('discussion', 2)
('di', 240)
('chemical', 6)
('prognosis', 6)
('lesions', 21)
('criterion', 2)
('2 h', 18)
('upregulation', 10)
('goat', 8)
('30 min', 16)
('monoclonal antibody', 2)
('lesion', 21)
('prostate cancers', 2)
('spot', 6)
('records', 2)
('invasion', 4)
('tumour progression', 2)
('data', 34)
('man', 40)
('short', 2)
('cell migration', 4)
('lines', 50)
('st', 516)
('room temperature', 12)
('correlation', 13)
('retrieval', 2)
('sd', 12)
('cancer prevention', 2)
('gynecology', 2)
('gynecologic oncologist', 2)
('antisense', 2)
('experiments', 18)
('fetal bovine serum', 2)
('obstetrics', 2)
('vitamin d', 3)
('staining', 32)
('cancer progression', 6)
('ovarian tumors', 26)
('group', 18)
('h2o2', 2)
('benign', 8)
('pcr', 54)
('presence', 18)
('internal control', 18)
('late', 98)
('absence', 6)
('molecular dynamics', 2)
('pcr analysis', 6)
('then', 18)
('material', 5)
('p11', 58)
('therapy', 4)
('rank', 9)
('compound', 19)
('not', 28)
('rna extraction', 4)
('progression', 16)
('only', 8)
('proteins', 6)
('micro', 18)
('slide', 10)
('mrna', 18)
('motif', 4)
('status', 2)
('cancer cells', 7)
('cell cycle arrest', 2)
('independent', 18)
('protein expression', 8)
('mda', 6)
('related', 10)
('solution', 6)
('antibodies', 6)
('molecular', 6)
('binding sites', 2)
('measurement', 4)
('laboratory', 4)
('extract', 12)
('penicillin', 2)
('buffers', 2)
('turn', 2)
('rt', 54)
('negative control', 6)
('borderline', 7)
('open', 2)
('20\\%', 14)
('viability', 4)
('mediated', 4)
('reader', 4)
('formula', 2)
('purine', 2)
('induction', 11)
('early detection', 2)
('roswell park cancer institute', 2)
('1\\+', 6)
('barrier', 2)
('derived', 6)
('ebss', 4)
('mechanisms', 6)
('free', 2)
('diagnostic', 4)
('oncogenesis', 2)
('statistics', 2)
('\\%\\ normal', 4)
('kit', 22)
('additional', 6)
('ethidium bromide', 2)
('microliters', 2)
('mrna expression', 2)
('austin', 2)
('first', 5)
('cellular proliferation', 2)
('clear cell', 4)
('probability', 2)
('number', 12)
('nacl', 4)
('one', 10)
('long', 25)
('specificity', 4)
('ihc', 20)
('array', 6)
('quality', 10)
('city', 8)
('little', 2)
('findings', 6)
('prostate', 4)
('system', 10)
('construct', 22)
('trend', 4)
('regulation', 31)
('clinical', 6)
('observations', 9)
('tom', 10)
('chemotherapy', 2)
('percentage', 4)
('ectopic expression', 10)
('final', 4)
('eb1089', 6)
('lipofectamine', 14)
('tool', 4)
('antitumor', 4)
('supernatant', 4)
('slides', 10)
('part', 2)
('formaldehyde', 2)
('favorable', 6)
('relative', 20)
('lipofectamine 2000', 6)
('target', 4)
('instruction', 8)
('18s', 2)
('patients', 61)
('intensities', 2)
('disease stages', 6)
('lysate', 8)
('outcome', 2)
('treated', 13)
('phosphatase inhibitor', 2)
('adjuvant', 2)
('membranes', 6)
('disease progression', 4)
('further', 3)
('need', 4)
('concentration', 16)
('late stage tumor', 8)
('contents', 2)
('forced', 17)
('100\\%', 4)
('reverse transcription', 4)
('transcription', 18)
('isolated', 4)
('mechanism', 8)
('mix', 18)
('cell types', 6)
('detector', 2)
('western blot analysis', 18)
('fcs', 2)
('normal', 83)
('buffer', 20)
('sulfonate', 2)
('incidence', 2)
('wells', 2)
('significant', 29)
('epithelial ovarian cancer', 2)
('probes', 2)
('stage iii', 14)
('streptomycin', 2)
('observation', 13)
('stage iia', 2)
('later', 2)
('lps', 2)
('survivin antibody', 2)
('order', 11)
('immunoreactivity', 2)
('protein concentration', 2)
('tubes', 2)
('mrc', 2)
('mtt assay', 10)
('selection', 2)
('probe', 10)
('cell-cell adhesion', 4)
('inconsistent', 2)
('threshold', 4)
('decade', 2)
('exposure time', 2)
('hrp', 8)
('enzyme', 2)
('actin', 12)
('screening', 4)
('rich', 6)
('identification', 2)
('selenium compound', 11)
('\\/ml', 8)
('mortality', 2)
('plate', 30)
('mixture', 10)
('histone', 4)
('tbs', 8)
('overall', 3)
('degradation', 2)
('breast', 4)
('salt', 2)
('new', 2)
('report', 13)
('untreated', 5)
('secondary', 4)
('elisa assay', 10)
('substrate', 2)
('real time pcr', 2)
('arbitrary unit', 2)
('\\%\\ positive\\ cells', 6)
('denmark', 2)
('tumors', 73)
('expression vector', 2)
('summary', 2)
('survivin', 135)
('activity', 31)
('relapse', 6)
('ets transcription factors', 4)
('characteristics', 6)
('h2a', 2)
('national', 4)
('approved protocol', 2)
('detection', 24)
('intensity', 12)
('result', 35)
('surgery', 6)
('reverse transcriptase', 2)
('centrifugation', 2)
('review', 8)
('currently', 2)
('total volume', 4)
('sites', 4)
('promega', 4)
('tumor suppressor', 4)
('score', 6)
('various', 6)
('membrane', 10)
('irb', 2)
('histones', 2)
('available', 2)
('sample size', 2)
('weak', 6)
('wi', 259)
('luciferase', 30)
('hypothesis', 2)
('recent', 2)
('leo', 6)
('exclusion', 6)
('reaction', 12)
('3\\+', 6)
('23', 8)
('equal', 4)
('drug', 2)
('expression', 210)
('adjusted', 4)
('luciferase activity', 16)
('cancer', 114)
('color', 2)
('selenium', 11)
('sequences', 2)
('table', 22)
('rpm', 10)
('better', 4)
('basis', 2)
('addition', 14)
('40\\%', 4)
('three', 2)
('reduction', 2)
('interest', 6)
('pe', 148)
('fig', 88)
('box', 4)
('risk estimate', 10)
('determination', 2)
('representative', 12)
('epithelial cell', 4)
('evidence', 6)
('applied', 4)
('novel', 2)
('statistical analysis', 2)
('double-stranded dna', 2)
('promoter', 37)
('2\\+', 6)
('procedure', 2)
('va', 332)
('vd', 58)
('reproducibility', 2)
('cell growth', 22)
('iv', 438)
('abts', 4)
('tissue', 72)
('tumor cell', 19)
('dual', 2)
('ia', 316)
('breast cancer cell', 2)
('protein', 36)
('80\\%', 6)
('ig', 217)
('definitive', 2)
('different', 34)
('trypan', 6)
('radiation', 2)
('same', 6)
('member', 2)
('microarray', 2)
('complex', 6)
('plates', 12)
('downregulation', 17)
('rna', 70)
('higher', 13)
('development', 4)
('transcription factor', 10)
('malignant tumours', 2)
('study design', 2)
('effect', 4)
('hand', 2)
('levels', 9)
('i-', 12)
('student', 2)
('immunohistochemical', 4)
('normalization', 10)
('cycle', 10)
('lower', 3)
('reagent', 16)
('isotype', 2)
('changes', 10)
('well', 42)
('analysis', 42)
('antiapoptotic', 2)
('components', 2)
('consistency', 2)
('quantitative', 14)
('model', 6)
('laboratories', 6)
('subtraction', 2)
('citrate buffer', 2)
('single spots', 2)
('accurate', 4)
('effects', 2)
('modalities', 2)
('50\\%', 2)
('human', 6)
('differentiation', 2)
('purified', 2)
('60\\%', 2)
('tables', 2)
('loading', 2)
('staging', 6)
('vivo', 6)
('density', 2)
('drive', 6)
('vitamin d3', 2)
('conjugated', 2)
('treatment', 35)
('invasive', 8)
('relevance', 6)
('transformation', 2)
('match', 2)
('bio', 20)
('increased', 1)
('bands', 2)
('survival', 32)
('cell lysate', 6)
('early', 29)
('cell adhesion', 6)
('inhibition', 15)
('dish', 2)
('toxicities', 2)
('loss', 30)
('rrna', 2)
('ovarian cancers', 4)
('analogs', 22)
('malignancy', 2)
('less than', 2)
('specific', 12)
('renilla luciferase', 6)
('night', 6)
('28s', 2)
('reduced', 17)
('stage ia', 6)
('methods', 9)
('sequence', 8)
('arrested', 2)
('cell line', 56)
('growth', 24)
('histology', 2)
('streptavidin', 4)
('intact', 2)
('light microscopy', 2)
('cell morphology', 10)
('whole cell', 2)
('tube', 4)
('measurements', 2)
('ice', 2)
('tma', 18)
('objective evidence', 2)
('core', 16)
('shaker', 2)
('hose', 31)
('coated', 4)
('90\\%', 2)
('paraffin-embedded', 2)
('step', 6)
('bp', 8)
('absorbance', 2)
('relative risk', 14)
('stage', 102)
('comparison', 8)
('island', 2)
('od', 97)
('statistically significant', 6)
('tumor', 168)
('cancer stage', 2)
('tailed', 6)
('concentrations', 2)
('renilla', 6)
('mean', 10)
('antibody', 22)
('block', 6)
('software', 2)
('growth suppression', 2)
('protease', 2)
('facility', 2)
('instruments', 2)
('image', 6)
('year', 4)
('two', 10)
('edta', 2)
('cell projection', 6)
('dehydrogenase', 2)
('prognostic marker', 5)
('log', 57)
('autoradiography', 2)
('ovarian tissue', 25)
('spots', 6)
('bromide', 4)
('low', 29)
('valencia', 2)
('synthesis', 2)
('function', 8)
('medium', 10)
('complete', 6)
('sds', 8)
('70\\%', 2)
('pdef', 368)
('expression level', 2)
('investigation', 2)
('heat', 2)
('good prognosis', 2)
('papillary serous adenocarcinoma', 2)
('line', 85)
('highest', 15)
('cancer cell', 39)
('cells', 86)
('rnas', 6)
('mtt', 14)
('cancers', 6)
('verification', 2)
('distribution', 8)
('stages', 24)
('similar', 12)
('stage iib', 6)
('clear cell carcinoma', 2)
('inadequate', 4)
('universal', 4)
('tissues', 60)
('metastasis', 8)
('bca', 2)
('stage iiia', 2)
('stage iiic', 6)
('epithelial', 8)
('lysis', 52)
('statistical significance', 2)
('tris', 6)
('pmol', 6)
('nm', 26)
('inactivation', 2)
('dna fragmentation', 6)
('ng', 329)
('ny', 20)
('prism', 2)
('setting', 2)
('role', 5)
('test', 21)
('mock', 14)
('poor', 2)
('transfection', 24)
('chemo', 4)
('anti-dna', 2)
('restoration', 4)
('previous', 17)
('cell death', 12)
('sigma', 4)
('gapdh', 8)
('stripping', 2)
('time', 35)
('angiogenesis', 2)
('h2b', 2)
('original', 2)


total: 768('cincinnati', 2)
('positive control', 2)
('duplicates', 2)
('excellent', 2)
('four', 6)
('microtiter plate', 2)
('tumours', 4)
('cagctgctcgatggc', 2)
('expressions', 2)
('primer', 12)
('duplicated', 2)
('inverse', 21)
('actin antibody', 2)
('tx', 2)
('recurrence', 6)
('0', 829)
('foster', 2)
('promoting', 2)
('tk', 6)
('endogenous', 10)
('cdna', 34)
('assay', 40)
('survival rate', 8)
('apoptosis', 54)
('activation', 8)
('radiation resistance', 2)
('figs', 8)
('rnase', 2)
('categories', 4)
('tri', 46)
('\\%\\ positive', 6)
('pdef-negative', 20)
('level', 29)
('evaluation', 3)
('prolonged', 5)
('tubes', 2)
('vector', 30)
('299', 2)
('inspection', 2)
('cell lines', 30)
('open', 2)
('-gggctgagtcctcaattttgaag-3', 2)
('ten', 30)
('triplicate', 2)
('195', 2)
('antigen', 2)
('consistent', 6)
('estimates', 8)
('biology', 2)
('understanding', 2)
('past', 2)
('fold', 4)
('rate', 42)
('ov432', 4)
('value', 12)
('patient', 79)
('elisa', 12)
('blue', 6)
('tumorigenicity', 2)
('abc', 4)
('sub', 24)
('abi', 18)
('section', 6)
('disease', 26)
('recommendation', 2)
('ovarian', 198)
('cell', 264)
('template', 4)
('international', 2)
('peroxidase activity', 2)
('method', 13)
('contrast', 2)
('proliferation', 30)
('tumor cell lines', 2)
('reporter', 4)
('normal tissue', 12)
('water', 2)
('tnm', 8)
('amplification', 4)
('groups', 8)
('100', 38)
('strong', 10)
('104', 8)
('skim milk', 4)
('study', 5)
('vectors', 4)
('reports', 2)
('chemical', 6)
('products', 10)
('usually', 4)
('reagents', 6)
('gene', 6)
('studies', 8)
('options', 2)
('\\/sub', 6)
('invasiveness', 4)
('diameter', 2)
('acggc-3', 2)
('ttcatccactg-3', 2)
('family', 4)
('highly', 6)
('marker', 7)
('tumor sample', 10)
('total', 32)
('estimate', 18)
('dna-lipofectamine', 4)
('warning signs', 2)
('skov6', 4)
('early detection', 2)
('cell proliferation', 16)
('positive', 50)
('control vector', 2)
('negative', 51)
('anti-histone', 2)
('few', 2)
('duplicate', 10)
('reproducibility', 2)
('black', 2)
('means', 2)
('manufacturer', 12)
('msa', 44)
('more', 9)
('0\\%', 52)
('mrc', 2)
('company', 2)
('constructs', 4)
('firefly luciferase activity', 2)
('transient', 4)
('biotin', 6)
('rabbit', 6)
('iib', 15)
('cases', 8)
('iii', 32)
('women', 2)
('high', 46)
('mg', 2)
('ma', 247)
('mb', 34)
('ml', 12)
('mo', 332)
('tissue procurement', 4)
('incubator', 2)
('values', 6)
('following', 10)
('inhibitor', 6)
('\xc2\xb5g', 34)
('10\\%', 14)
('il', 98)
('control', 37)
('motility', 2)
('ovarian tumour', 8)
('agarose gel', 4)
('sample', 35)
('death', 14)
('numbers', 4)
('sense', 4)
('western blot', 32)
('drive', 6)
('-tcagatggggtgcacgaactggt-3', 2)
('presumptive', 2)
('discussion', 2)
('histone', 4)
('serum', 8)
('ovarian tumors', 26)
('prognosis', 6)
('lesions', 21)
('criterion', 2)
('2 h', 18)
('upregulation', 10)
('goat', 8)
('30 min', 16)
('monoclonal antibody', 2)
('lesion', 21)
('prognostic', 5)
('prostate cancers', 2)
('reaction', 12)
('spot', 6)
('pluc-survivin', 2)
('records', 2)
('invasion', 4)
('tumour progression', 2)
('revealed', 6)
('man', 40)
('primers', 10)
('cell migration', 4)
('lines', 50)
('st', 516)
('room temperature', 12)
('correlation', 13)
('retrieval', 2)
('sd', 12)
('cancer prevention', 2)
('cell projection', 6)
('gynecology', 2)
('gynecologic oncologist', 2)
('antisense', 2)
('experiments', 18)
('fetal bovine serum', 2)
('obstetrics', 2)
('vitamin d', 3)
('staining', 32)
('protease', 2)
('25', 22)
('26', 10)
('group', 18)
('h2o2', 2)
('benign', 8)
('pcr', 54)
('presence', 18)
('28', 20)
('late', 98)
('absence', 6)
('molecular dynamics', 2)
('lipofectamine 2000', 6)
('pcr analysis', 6)
('suppressor', 4)
('then', 18)
('material', 5)
('fig', 88)
('p11', 58)
('therapy', 4)
('rank', 9)
('arrested', 2)
('compound', 19)
('not', 28)
('real time pcr', 2)
('rna extraction', 4)
('pbs', 14)
('only', 8)
('pc3', 4)
('proteins', 6)
('micro', 18)
('slide', 10)
('mrna', 18)
('mean', 10)
('status', 2)
('cancer cells', 7)
('cell cycle arrest', 2)
('independent', 18)
('protein expression', 8)
('mda', 6)
('related', 10)
('solution', 6)
('molecular', 6)
('binding sites', 2)
('measurement', 4)
('laboratory', 4)
('80', 28)
('extract', 12)
('penicillin', 2)
('buffers', 2)
('turn', 2)
('shaking\\.', 2)
('negative control', 6)
('borderline', 7)
('factors', 6)
('quality', 10)
('20\\%', 14)
('viability', 4)
('mediated', 4)
('reader', 4)
('formula', 2)
('purine', 2)
('induction', 11)
('selenium', 11)
('glyceraldehyde-3-phosphate', 2)
('roswell park cancer institute', 2)
('1\\+', 6)
('barrier', 2)
('derived', 6)
('ebss', 4)
('mechanisms', 6)
('free', 2)
('diagnostic', 4)
('oncogenesis', 2)
('statistics', 2)
('\\%\\ normal', 4)
('hand', 2)
('additional', 6)
('\\/\\+', 24)
('ethidium bromide', 2)
('microliters', 2)
('mrna expression', 2)
('austin', 2)
('first', 5)
('cellular proliferation', 2)
('clear cell', 4)
('probability', 2)
('number', 12)
('nacl', 4)
('one', 10)
('tek', 2)
('long', 25)
('specificity', 4)
('ihc', 20)
('array', 6)
('\xc3\x97', 16)
('city', 8)
('little', 2)
('findings', 6)
('prostate', 4)
('system', 10)
('construct', 22)
('ovarian cancer', 86)
('regulation', 31)
('2', 370)
('eb1089', 6)
('tom', 10)
('chemotherapy', 2)
('percentage', 4)
('ectopic expression', 10)
('final', 4)
('observations', 9)
('lipofectamine', 14)
('relative', 20)
('relative risk', 14)
('antibodies', 6)
('slides', 10)
('part', 2)
('formaldehyde', 2)
('favorable', 6)
('10', 156)
('b', 708)
('target', 4)
('19', 18)
('instruction', 8)
('isotype', 2)
('patients', 61)
('intensities', 2)
('disease stages', 6)
('lysate', 8)
('outcome', 2)
('treated', 13)
('phosphatase inhibitor', 2)
('and', 484)
('adjuvant', 2)
('membranes', 6)
('disease progression', 4)
('further', 3)
('need', 4)
('concentration', 16)
('late stage tumor', 8)
('contents', 2)
('forced', 17)
('100\\%', 4)
('reverse transcription', 4)
('transcription', 18)
('isolated', 4)
('mechanism', 8)
('mix', 18)
('biotinylated', 2)
('cell types', 6)
('peroxidase', 2)
('western blot analysis', 18)
('tool', 4)
('fcs', 2)
('normal', 83)
('buffer', 20)
('antitumor', 4)
('sulfonate', 2)
('incidence', 2)
('wells', 2)
('consistency', 2)
('75', 2)
('significant', 29)
('epithelial ovarian cancer', 2)
('probes', 2)
('stage iii', 14)
('laboratories', 6)
('observation', 13)
('stage iia', 2)
('year', 4)
('stage iib', 6)
('lps', 2)
('survivin antibody', 2)
('order', 11)
('immunoreactivity', 2)
('hrpo-conjugated', 2)
('protein concentration', 2)
('sigma', 4)
('\\\xe2\\\x80\\\x9cggaa\\/t', 2)
('h2b', 2)
('mtt assay', 10)
('selection', 2)
('probe', 10)
('cell-cell adhesion', 4)
('inconsistent', 2)
('threshold', 4)
('data', 34)
('decade', 2)
('exposure time', 2)
('hrp', 8)
('short', 2)
('enzyme', 2)
('actin', 12)
('screening', 4)
('rich', 6)
('factor', 10)
('cancer progression', 6)
('identification', 2)
('selenium compound', 11)
('\\/ml', 8)
('mortality', 2)
('plate', 30)
('mixture', 10)
('activity\\.', 9)
('tbs', 8)
('overall', 3)
('degradation', 2)
('breast', 4)
('salt', 2)
('new', 2)
('report', 13)
('untreated', 5)
('secondary', 4)
('elisa assay', 10)
('substrate', 2)
('pcdna3\\.1', 32)
('arbitrary unit', 2)
('\\%\\ positive\\ cells', 6)
('denmark', 2)
('tumors', 73)
('expression vector', 2)
('summary', 2)
('survivin', 135)
('activity', 31)
('relapse', 6)
('ets transcription factors', 4)
('national', 4)
('approved protocol', 2)
('detection', 24)
('intensity', 12)
('result', 35)
('ebs', 6)
('surgery', 6)
('reverse transcriptase', 2)
('centrifugation', 2)
('18s', 2)
('review', 8)
('currently', 2)
('total volume', 4)
('sites', 4)
('promega', 4)
('tumor suppressor', 4)
('score', 6)
('various', 6)
('membrane', 10)
('irb', 2)
('histones', 2)
('available', 2)
('sample size', 2)
('weak', 6)
('wi', 259)
('fig\\.', 56)
('loading', 2)
('hypothesis', 2)
('recent', 2)
('vitamin d3', 2)
('leo', 6)
('exclusion', 6)
('ets', 16)
('1640', 6)
('3\\+', 6)
('region', 4)
('23', 8)
('equal', 4)
('drug', 2)
('figures', 2)
('tma\\.', 4)
('expression', 210)
('progression', 16)
('adjusted', 4)
('luciferase activity', 16)
('cancer', 114)
('color', 2)
('internal control', 18)
('60', 10)
('anti', 72)
('65', 2)
('sequences', 2)
('table', 22)
('rpm', 10)
('rpci', 6)
('better', 4)
('tumour', 28)
('basis', 2)
('addition', 14)
('40\\%', 4)
('three', 2)
('reduction', 2)
('change', 20)
('interest', 6)
('pe', 148)
('clinical', 6)
('trend', 4)
('monoclonal', 2)
('treatment', 35)
('box', 4)
('survivin-positive', 3)
('risk estimate', 10)
('tbs-t', 8)
('determination', 2)
('representative', 12)
('epithelial cell', 4)
('evidence', 6)
('applied', 4)
('novel', 2)
('statistical analysis', 2)
('double-stranded dna', 2)
('promoter', 37)
('n', 4974)
('rpmi', 8)
('match', 2)
('2\\+', 6)
('di', 240)
('procedure', 2)
('va', 332)
('motif', 4)
('characteristics', 6)
('cell growth', 22)
('binding', 2)
('iv', 438)
('ii', 53)
('abts', 4)
('tissue', 72)
('tumor cell', 19)
('dual', 2)
('ia', 316)
('breast cancer cell', 2)
('protein', 36)
('80\\%', 6)
('ig', 217)
('definitive', 2)
('different', 34)
('trypan', 6)
('invasion\\.', 2)
('radiation', 2)
('same', 6)
('member', 2)
('microarray', 2)
('complex', 6)
('plates', 12)
('downregulation', 17)
('survival', 32)
('higher', 13)
('development', 4)
('transcription factor', 10)
('dna-histon', 2)
('malignant tumours', 2)
('study design', 2)
('effect', 4)
('kit', 22)
('levels', 9)
('i-', 12)
('student', 2)
('immunohistochemical', 4)
('normalization', 10)
('cycle', 10)
('lower', 3)
('reagent', 16)
('i', 5454)
('changes', 10)
('well', 42)
('analysis', 42)
('antiapoptotic', 2)
('1', 483)
('-gaggctggc', 2)
('components', 2)
('methods\\.', 2)
('quantitative', 14)
('model', 6)
('streptomycin', 2)
('subtraction', 2)
('citrate buffer', 2)
('single spots', 2)
('pdefpcr', 2)
('accurate', 4)
('mda-mb-231', 2)
('effects', 2)
('modalities', 2)
('50\\%', 2)
('human', 6)
('differentiation', 2)
('purified', 2)
('60\\%', 2)
('tables', 2)
('vd3', 52)
('luciferase', 30)
('staging', 6)
('vivo', 6)
('density', 2)
('\\>', 16)
('\\?', 54)
('\\=', 122)
('toxicities', 2)
('\\%', 122)
('conjugated', 2)
('4', 171)
('invasive', 8)
('relevance', 6)
('5', 219)
('transformation', 2)
('\\(', 489)
('\\)', 489)
('bio', 20)
('increased', 1)
('bands', 2)
('rna', 70)
('cell lysate', 6)
('early', 29)
('cell adhesion', 6)
('inhibition', 15)
('dish', 2)
('detector', 2)
('loss', 30)
('rrna', 2)
('58', 6)
('analogs', 22)
('vd', 58)
('malignancy', 2)
('50', 58)
('tumors\\.', 6)
('specific', 12)
('supernatant', 4)
('renilla luciferase', 6)
('night', 6)
('28s', 2)
('reduced', 17)
('stage ia', 6)
('methods', 9)
('sequence', 8)
('fl-142', 2)
('cell line', 56)
('less than', 2)
('growth', 24)
('histology', 2)
('streptavidin', 4)
('prostate-derived', 2)
('intact', 2)
('light microscopy', 2)
('cell morphology', 10)
('whole cell', 2)
('tube', 4)
('measurements', 2)
('ice', 2)
('tma', 18)
('survivin\\.', 4)
('moderate', 8)
('objective evidence', 2)
('core', 16)
('shaker', 2)
('hose', 31)
('coated', 4)
('90\\%', 2)
('skov3', 4)
('paraffin-embedded', 2)
('167-bp', 2)
('step', 6)
('bp', 8)
('absorbance', 2)
('dna', 54)
('stage', 102)
('comparison', 8)
('island', 2)
('msa\\.', 6)
('od', 97)
('statistically significant', 6)
('tumor', 168)
('cancer stage', 2)
('tailed', 6)
('concentrations', 2)
('renilla', 6)
('antibody', 22)
('block', 6)
('software', 2)
('growth suppression', 2)
('anti-dna-hrp', 2)
('facility', 2)
('instruments', 2)
('image', 6)
('-gtgaggagagctggaccgac-3', 2)
('h4', 2)
('two', 10)
('2\\.8\\-kb', 4)
('pdef\\.', 4)
('edta', 2)
('pdef\\+', 4)
('dehydrogenase', 2)
('prognostic marker', 5)
('log', 57)
('autoradiography', 2)
('ovarian tissue', 25)
('spots', 6)
('avidin\xe2\x80\x93biotin', 2)
('bromide', 4)
('low', 29)
('valencia', 2)
('synthesis', 2)
('function', 8)
('medium', 10)
('complete', 6)
('sds', 8)
('70\\%', 2)
('pdef', 368)
('criteria', 4)
('expression level', 2)
('investigation', 2)
('heat', 2)
('good prognosis', 2)
('papillary serous adenocarcinoma', 2)
('line', 85)
('highest', 15)
('cancer cell', 39)
('cells', 86)
('rnas', 6)
('mtt', 14)
('pbs\\.', 2)
('cancers', 6)
('verification', 2)
('distribution', 8)
('stages', 24)
('similar', 12)
('later', 2)
('clear cell carcinoma', 2)
('inadequate', 4)
('universal', 4)
('tissues', 60)
('metastasis', 8)
('gapdh', 8)
('stage iiia', 2)
('stage iiic', 6)
('epithelial', 8)
('lysis', 52)
('statistical significance', 2)
('tris', 6)
('pmol', 6)
('nm', 26)
('inactivation', 2)
('prl-tk', 4)
('dna fragmentation', 6)
('40', 41)
('ng', 329)
('ny', 20)
('prism', 2)
('setting', 2)
('role', 5)
('test', 21)
('mock', 14)
('-gcttcccgttctcagccttgac-3', 2)
('poor', 2)
('rt', 54)
('transfection', 24)
('time', 35)
('anti-dna', 2)
('8\\/13', 4)
('restoration', 4)
('previous', 17)
('angiogenesis', 2)
('cell death', 12)
('h2a', 2)
('bca', 2)
('stripping', 2)
('ovarian cancers', 4)
('chemo', 4)
('cores', 4)
('2008', 16)
('pdef-specific', 4)
('original', 2)
